Zohran Mamdani Wants You to Boycott Starbucks – Business Insider

YouTube TV has confirmed plans to launch a series of lower-cost, genre-focused subscription tiers in early 2026, marking the most significant restructuring of its live television offering since the service debuted in 2017. The new lineup, branded YouTube TV Plans, will consist of more than ten specialized packages built around sports, news, kids and family…

At the Fed’s press conference, Fed Chair Jerome Powell acknowledged that many consumers are struggling with higher inflation. “We hear loud and clear” the concerns about affordability, Powell said. But what Powell and the Fed can do about affordability is a different story. “There’s actually not much they can do about that,” Apollo chief economist…

Amazon is reportedly preparing to cut up to 14,000 jobs, many of which could be in Washington state, as part of a broader workforce reduction, according to Reuters. The announcement follows a previous layoff round last year, which saw thousands of positions cut from the company. Washington State’s Employment Security Department listed Amazon on its…

For many executives, climbing to the top of the corporate ladder comes with clear perks—corner offices, big salaries, and the ability to steer strategy in real time. It also means that work is never far from mind. For Cisco’s chief product officer, Jeetu Patel, that reality translates into working seven days a week, typically starting…

There are all sorts of New Year’s superstitions that are supposed to make sure the new year is a good one. Some cultures consider it good to break glass on New Year’s to chase away evil spirits. Others think you should eat 12 grapes at the stroke of midnight to ensure 12 months of good…

Bagsværd, Denmark, 24 November 2025 – Novo Nordisk today announced the top-line results from the 2-year primary analysis of evoke and evoke+ phase 3 trials in early-stage symptomatic Alzheimer’s disease. The two trials were randomised, double-blinded, enrolled a total of 3808 adults and evaluated the efficacy and safety of oral semaglutide compared to placebo on top…